249 related articles for article (PubMed ID: 29295493)
21. Enhancing the efficacy of hepatocellular carcinoma chemotherapeutics with natural anticancer agents.
Alisi A; Balsano C
Nutr Rev; 2007 Dec; 65(12 Pt 1):550-3. PubMed ID: 18236694
[TBL] [Abstract][Full Text] [Related]
22. Bitter melon: antagonist to cancer.
Nerurkar P; Ray RB
Pharm Res; 2010 Jun; 27(6):1049-53. PubMed ID: 20198408
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and dietary phytochemicals: Role in cancer chemoprevention and treatment.
Chikara S; Nagaprashantha LD; Singhal J; Horne D; Awasthi S; Singhal SS
Cancer Lett; 2018 Jan; 413():122-134. PubMed ID: 29113871
[TBL] [Abstract][Full Text] [Related]
24. 60th ASTRO Annual Meeting.
Lai C
Lancet Oncol; 2018 Dec; 19(12):e679-e680. PubMed ID: 30509887
[No Abstract] [Full Text] [Related]
25. Cancer chemoprevention by natural carotenoids as an efficient strategy.
Bolhassani A
Anticancer Agents Med Chem; 2015; 15(8):1026-31. PubMed ID: 25731177
[TBL] [Abstract][Full Text] [Related]
26. Vitamin E and cancer.
Negis Y; Zingg JM; Libinaki R; Meydani M; Azzi A
Nutr Cancer; 2009; 61(6):875-8. PubMed ID: 20155629
[TBL] [Abstract][Full Text] [Related]
27. Plant coumestans: recent advances and future perspectives in cancer therapy.
Nehybová T; Šmarda J; Beneš P
Anticancer Agents Med Chem; 2014; 14(10):1351-62. PubMed ID: 25019627
[TBL] [Abstract][Full Text] [Related]
28. [Green tea, a promising source of novel antitumor drugs?].
Korman DB
Vopr Onkol; 2010; 56(3):262-71. PubMed ID: 20804046
[No Abstract] [Full Text] [Related]
29. Polyphenolic Phytochemicals in Cancer Prevention and Therapy: Bioavailability versus Bioefficacy.
Estrela JM; Mena S; Obrador E; Benlloch M; Castellano G; Salvador R; Dellinger RW
J Med Chem; 2017 Dec; 60(23):9413-9436. PubMed ID: 28654265
[TBL] [Abstract][Full Text] [Related]
30. Are the antagonists of the renin-angiotensin system also anticancer agents?
Lonati C; Morganti A
High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):99-102. PubMed ID: 24916368
[TBL] [Abstract][Full Text] [Related]
31. Should we stop investing in chemoprevention trials in oncology?
Weller D; Wender RC
Lancet Oncol; 2019 Jun; 20(6):766-767. PubMed ID: 31162091
[No Abstract] [Full Text] [Related]
32. Second international cancer chemoprevention conference.
Benner SE; Pastorino U; Lippman SM; Hong WK
Cancer Res; 1994 Feb; 54(3):854-6. PubMed ID: 7905788
[No Abstract] [Full Text] [Related]
33. A reappraisal of the potential chemopreventive and chemotherapeutic properties of resveratrol.
Gusman J; Malonne H; Atassi G
Carcinogenesis; 2001 Aug; 22(8):1111-7. PubMed ID: 11470738
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation by selected dietary phytochemicals in cancer chemoprevention.
Shukla S; Meeran SM; Katiyar SK
Cancer Lett; 2014 Dec; 355(1):9-17. PubMed ID: 25236912
[TBL] [Abstract][Full Text] [Related]
35. Cancer chemoprevention by dietary phytochemicals: promises and pitfalls.
Priyadarsini RV; Nagini S
Curr Pharm Biotechnol; 2012 Jan; 13(1):125-36. PubMed ID: 21466433
[TBL] [Abstract][Full Text] [Related]
36. Advances in viral oncology research: summary of the 3rd International Meeting.
Tornesello ML; Buonaguro L; Buonaguro FM
Expert Rev Vaccines; 2012 Apr; 11(4):411-4. PubMed ID: 22551025
[TBL] [Abstract][Full Text] [Related]
37. Emphasizing the provocative.
Rose S
Cancer Discov; 2012 Nov; 2(11):968. PubMed ID: 23148360
[No Abstract] [Full Text] [Related]
38. Editorial: current advances in cancer prevention and treatment by natural products.
Bishayee A
Curr Pharm Biotechnol; 2012 Jan; 13(1):115-6. PubMed ID: 21466439
[No Abstract] [Full Text] [Related]
39. Antioxidants and cancer.
Stebbing J; Hart CA
Lancet Oncol; 2011 Oct; 12(11):996. PubMed ID: 21968225
[No Abstract] [Full Text] [Related]
40. Inside ASCO 2014.
Oncology (Williston Park); 2014 Jul; 28(7):643-8. PubMed ID: 25144289
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]